Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 1 1

Status

Recruiting 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Myasthenia Gravis 2Strabismus 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Emergence Delirium 1

Interventions

pembrolizumab 589Cyclophosphamide 539Magnetic Resonance Spectroscopy 523Radiotherapy 506Specimen Handling 503Nivolumab 407Cisplatin 370Carboplatin 358Biopsy 304Blood Specimen Collection 295Radiosurgery 283Paclitaxel 274Surveys and Questionnaires 268Standard of Care 266Gemcitabine 265fludarabine 261Dexamethasone 258Drug Therapy 256venetoclax 246Bevacizumab 246Oxaliplatin 206Rituximab 195Capecitabine 194Radiation 189Fluorouracil 186Ipilimumab 184durvalumab 180Doxorubicin 175atezolizumab 172Etoposide 171

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Pyridostigmine Bromide × 1 year × Clear all
NCT06035757 2026-03-03

The Occurrence of Emergence Agitation in Pediatric Strabismus Surgery

Konkuk University Medical Center

Phase 4 Recruiting
76 enrolled
LymphoidOther hematologic neoplasm

Emergence Delirium, Strabismus, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04182984 2026-01-30

TREAT-OMG

Tang-Du Hospital

Recruiting
200 enrolled

Myasthenia Gravis

NCT07154095 2025-09-04

A Single-Center, Randomized, Open-Label, Two-Sequence, Two-Period, Crossover Study Comparing the Pharmacokinetics and Safety of Pyridostigmine Sustained-Release and Immediate-Release Tablets Following Single and Multiple Doses in Healthy Chinese Participants

West China Second University Hospital

Phase 1 Completed
40 enrolled

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡